Trial
NCT03056638
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Ferring Pharmaceuticals; University of Texas Southwestern Medical Center; University of Michigan
Condition
Prostate Cancer
Intervention
Degarelix
Why stopped
Due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-28